AAAAAA

   
Results: 1-25 | 26-31
Results: 1-25/31
DEVELOPMENT OF LYS TO ARG MUTATION AT CODON-70 OF THE REVERSE-TRANSCRIPTASE GENE OF HIV-1 DURING ZIDOVUDINE MONOTHERAPY AND ALTERNATING ZIDOVUDINE DIDANOSINE THERAPY/
Authors: BRUUN L KATZENSTEIN T GERSTOFT J PEDERSEN C MATHIESEN LR NIELSEN C
Citation: L. Bruun et al., DEVELOPMENT OF LYS TO ARG MUTATION AT CODON-70 OF THE REVERSE-TRANSCRIPTASE GENE OF HIV-1 DURING ZIDOVUDINE MONOTHERAPY AND ALTERNATING ZIDOVUDINE DIDANOSINE THERAPY/, Antiviral therapy, 3(2), 1998, pp. 89-95
INCREASED LEVELS OF SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTOR-I(P55) ANDDECREASED IGG1 REACTIVITIES IN HIV-1 PATIENTS WITH CYTOMEGALOVIRUS DISEASE
Authors: JAKOBSEN PH DODT KK MEYER CN KATZENSTEIN T GERSTOFT J SKINHOJ P
Citation: Ph. Jakobsen et al., INCREASED LEVELS OF SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTOR-I(P55) ANDDECREASED IGG1 REACTIVITIES IN HIV-1 PATIENTS WITH CYTOMEGALOVIRUS DISEASE, Scandinavian journal of immunology, 47(6), 1998, pp. 591-595
THE RELATIVE PROGNOSTIC VALUE OF PLASMA HIV RNA LEVELS AND CD4 LYMPHOCYTE COUNTS IN ADVANCED HIV-INFECTION
Authors: LEPRI AC KATZENSTEIN TL ULLUM H PHILLIPS AN SKINHOJ P GERSTOFT J PEDERSEN BK
Citation: Ac. Lepri et al., THE RELATIVE PROGNOSTIC VALUE OF PLASMA HIV RNA LEVELS AND CD4 LYMPHOCYTE COUNTS IN ADVANCED HIV-INFECTION, AIDS, 12(13), 1998, pp. 1639-1643
AN AGGRESSIVE AND INVASIVE GROWTH OF JUVENILE PAPILLOMAS INVOLVING THE TOTAL RESPIRATORY-TRACT
Authors: PETERSEN BL BUCHWALD C GERSTOFT J BRETLAU P LINDEBERG H
Citation: Bl. Petersen et al., AN AGGRESSIVE AND INVASIVE GROWTH OF JUVENILE PAPILLOMAS INVOLVING THE TOTAL RESPIRATORY-TRACT, Journal of Laryngology and Otology, 112(11), 1998, pp. 1101-1104
CERVICAL HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SHEDDING IS ASSOCIATED WITH GENITAL BETA-CHEMOKINE SECRETION
Authors: IVERSEN AKN FUGGER L EUGENOLSEN J BALSLEV U JENSEN T WAHL S GERSTOFT J MULLINS JI SKINHOJ P
Citation: Akn. Iversen et al., CERVICAL HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SHEDDING IS ASSOCIATED WITH GENITAL BETA-CHEMOKINE SECRETION, The Journal of infectious diseases, 178(5), 1998, pp. 1334-1342
DISTINCT DETERMINANTS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA AND DNA LOADS IN VAGINAL AND CERVICAL SECRETIONS
Authors: IVERSEN AKN LARSEN AR JENSEN T FUGGER L BALSLEV U WAHL S GERSTOFT J MULLINS JI SKINHOJ P
Citation: Akn. Iversen et al., DISTINCT DETERMINANTS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA AND DNA LOADS IN VAGINAL AND CERVICAL SECRETIONS, The Journal of infectious diseases, 177(5), 1998, pp. 1214-1220
PRODUCTION OF BETA-CHEMOKINES IN HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION - EVIDENCE THAT HIGH-LEVELS OF MACROPHAGE IN INFLAMMATORY PROTEIN-1-BETA ARE ASSOCIATED WITH A DECREASED RISK OF HIV DISEASE PROGRESSION
Authors: ULLUM H LEPRI AC VICTOR J ALADDIN H PHILLIPS AN GERSTOFT J SKINHOJ P PEDERSEN BK
Citation: H. Ullum et al., PRODUCTION OF BETA-CHEMOKINES IN HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION - EVIDENCE THAT HIGH-LEVELS OF MACROPHAGE IN INFLAMMATORY PROTEIN-1-BETA ARE ASSOCIATED WITH A DECREASED RISK OF HIV DISEASE PROGRESSION, The Journal of infectious diseases, 177(2), 1998, pp. 331-336
PROGNOSTIC VALUE OF SERUM HIV-RNA LEVELS AT VIROLOGICAL STEADY-STATE AFTER SEROCONVERSION - RELATION TO CD4 CELL COUNT AND CLINICAL COURSE OF PRIMARY INFECTION
Authors: PEDERSEN C KATZENSTEIN T NIELSEN C LUNDGREN JD GERSTOFT J
Citation: C. Pedersen et al., PROGNOSTIC VALUE OF SERUM HIV-RNA LEVELS AT VIROLOGICAL STEADY-STATE AFTER SEROCONVERSION - RELATION TO CD4 CELL COUNT AND CLINICAL COURSE OF PRIMARY INFECTION, Journal of acquired immune deficiency syndromes and human retrovirology, 16(2), 1997, pp. 93-99
HIV-INFECTED INDIVIDUALS WITH THE CCR5-DELTA-32 CCR5 GENOTYPE HAVE LOWER HIV RNA LEVELS AND HIGHER CD4 CELL COUNTS IN THE EARLY YEARS OF THE INFECTION THAN DO PATIENTS WITH THE WILD-TYPE/
Authors: KATZENSTEIN TL EUGENOLSEN J HOFMANN B BENFIELD T PEDERSEN C IVERSEN AKN SORENSEN AM GARRED P KOPPELHUS U SVEJGAARD A GERSTOFT J
Citation: Tl. Katzenstein et al., HIV-INFECTED INDIVIDUALS WITH THE CCR5-DELTA-32 CCR5 GENOTYPE HAVE LOWER HIV RNA LEVELS AND HIGHER CD4 CELL COUNTS IN THE EARLY YEARS OF THE INFECTION THAN DO PATIENTS WITH THE WILD-TYPE/, Journal of acquired immune deficiency syndromes and human retrovirology, 16(1), 1997, pp. 10-14
INCREASED PLASMA HIV TYPE-1 RNA LEVELS ARE ASSOCIATED WITH LOW-LEVELSOF NON-MHC CLASS I-RESTRICTED CYTOTOXICITY
Authors: ULLUM H KATZENSTEIN T GERSTOFT J SKINHOJ P PEDERSEN BK
Citation: H. Ullum et al., INCREASED PLASMA HIV TYPE-1 RNA LEVELS ARE ASSOCIATED WITH LOW-LEVELSOF NON-MHC CLASS I-RESTRICTED CYTOTOXICITY, AIDS research and human retroviruses, 13(3), 1997, pp. 217-218
SURVIVAL OF AIDS PATIENTS ACCORDING TO TYPE OF AIDS-DEFINING EVENT
Authors: MOCROFT AJ LUNDGREN JD MONFORTE AD LEDERGERBER B BARTON SE VELLA S KATLAMA C GERSTOFT J PEDERSEN C PHILLIPS AN
Citation: Aj. Mocroft et al., SURVIVAL OF AIDS PATIENTS ACCORDING TO TYPE OF AIDS-DEFINING EVENT, International journal of epidemiology, 26(2), 1997, pp. 400-407
HETEROZYGOSITY FOR A DELETION IN THE CKR-5 GENE LEADS TO PROLONGED AIDS-FREE SURVIVAL AND SLOWER CD4 T-CELL DECLINE IN A COHORT OF HIV-SEROPOSITIVE INDIVIDUALS
Authors: EUGENOLSEN J IVERSEN AKN GARRED P KOPPELHUS U PEDERSEN C BENFIELD TL SORENSEN AM KATZENSTEIN T DICKMEISS E GERSTOFT J SKINHOJ P SVEJGAARD A NIELSEN JO HOFMANN B
Citation: J. Eugenolsen et al., HETEROZYGOSITY FOR A DELETION IN THE CKR-5 GENE LEADS TO PROLONGED AIDS-FREE SURVIVAL AND SLOWER CD4 T-CELL DECLINE IN A COHORT OF HIV-SEROPOSITIVE INDIVIDUALS, AIDS, 11(3), 1997, pp. 305-310
DUAL EFFECT OF CCR5 DELTA-32 GENE DELETION IN HIV-1-INFECTED PATIENTS
Authors: GARRED P EUGENOLSEN J IVERSEN AKN BENFIELD TL SVEJGAARD A HOFMANN B KOPPELHUS U PEDERSEN C SORENSEN AM KATZENSTEIN T GERSTOFT J SKINHOJ P NIELSEN JO DICKMEISS E
Citation: P. Garred et al., DUAL EFFECT OF CCR5 DELTA-32 GENE DELETION IN HIV-1-INFECTED PATIENTS, Lancet, 349(9069), 1997, pp. 1884-1884
RANDOMIZED TRIAL OF ADDITION OF LAMIVUDINE OR LAMIVUDINE PLUS LOVIRIDE TO ZIDOVUDINE-CONTAINING REGIMENS FOR PATIENTS WITH HIV-1 INFECTION - THE CAESAR TRIAL
Authors: COOPER DA KATLAMA C MONTANER J COLLIS PJ ANTUNES F ATKINSON M CLARK A CLUMECK N COLLIS P GAZZARD B GERSTOFT J GOH L HILL A KORSIA S LANGE J MCCALLUM L MCDADE H MALLOLAS J MORONI M NORKRANS G OPRAVIL M REISS P ROZENBAUM W SCOTT J SMITH D STASZEWSKI S STOFFELS P
Citation: Da. Cooper et al., RANDOMIZED TRIAL OF ADDITION OF LAMIVUDINE OR LAMIVUDINE PLUS LOVIRIDE TO ZIDOVUDINE-CONTAINING REGIMENS FOR PATIENTS WITH HIV-1 INFECTION - THE CAESAR TRIAL, Lancet, 349(9063), 1997, pp. 1413-1421
SUSCEPTIBILITY TO HIV-INFECTION AND PROGRESSION OF AIDS IN RELATION TO VARIANT ALLELES OF MANNOSE-BINDING LECTIN
Authors: GARRED P MADSEN HO BALSLEV U HOFMANN B PEDERSEN C GERSTOFT J SVEJGAARD A
Citation: P. Garred et al., SUSCEPTIBILITY TO HIV-INFECTION AND PROGRESSION OF AIDS IN RELATION TO VARIANT ALLELES OF MANNOSE-BINDING LECTIN, Lancet, 349(9047), 1997, pp. 236-240
A BROAD-SPECTRUM CHEMOKINE ANTAGONIST ENCODED BY KAPOSIS SARCOMA-ASSOCIATED HERPESVIRUS
Authors: KLEDAL TN ROSENKILDE MM COULIN F SIMMONS G JOHNSEN AH ALOUANI S POWER CA LUTTICHAU HR GERSTOFT J CLAPHAM PR CLARKLEWIS I WELLS TNC SCHWARTZ TW
Citation: Tn. Kledal et al., A BROAD-SPECTRUM CHEMOKINE ANTAGONIST ENCODED BY KAPOSIS SARCOMA-ASSOCIATED HERPESVIRUS, Science, 277(5332), 1997, pp. 1656-1659
TOXOPLASMOSIS IN DANISH AIDS PATIENTS
Authors: GARLY ML PETERSEN E PEDERSEN C LUNDGREN JD GERSTOFT J
Citation: Ml. Garly et al., TOXOPLASMOSIS IN DANISH AIDS PATIENTS, Scandinavian journal of infectious diseases, 29(6), 1997, pp. 597-600
ALTERNATING TREATMENT WITH DIDANOSINE AND ZIDOVUDINE VERSUS EITHER DRUG ALONE FOR THE TREATMENT OF ADVANCED HIV-INFECTION - THE ALTER STUDY
Authors: GERSTOFT J MELANDER H BRUUN JN PEDERSEN C GOTZSCHE PC BERGLUND O MATHIESEN L SKINHOJ P NORRBY SR
Citation: J. Gerstoft et al., ALTERNATING TREATMENT WITH DIDANOSINE AND ZIDOVUDINE VERSUS EITHER DRUG ALONE FOR THE TREATMENT OF ADVANCED HIV-INFECTION - THE ALTER STUDY, Scandinavian journal of infectious diseases, 29(2), 1997, pp. 121-128
DECREASED SHORT-TERM PRODUCTION OF TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-1-BETA IN HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE SUBJECTS
Authors: ULLUM H VICTOR J KATZENSTEIN TL GERSTOFT J GOTZSCHE PC BENDTZEN K SKINHOJ P PEDERSEN BK
Citation: H. Ullum et al., DECREASED SHORT-TERM PRODUCTION OF TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-1-BETA IN HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE SUBJECTS, The Journal of infectious diseases, 175(6), 1997, pp. 1507-1510
EPIDEMIOLOGY OF AIDS-RELATED KAPOSIS-SARCOMA IN EUROPE OVER 10 YEARS
Authors: HERMANS P LUNDGREN J SOMMEREIJNS B PEDERSEN C VELLA S KATLAMA C LUTHY R PINCHING AJ GERSTOFT J PEHRSON P CLUMECK N
Citation: P. Hermans et al., EPIDEMIOLOGY OF AIDS-RELATED KAPOSIS-SARCOMA IN EUROPE OVER 10 YEARS, AIDS, 10(8), 1996, pp. 911-917
DEVELOPMENT OF RESISTANCE TO ZIDOVUDINE (ZDV) AND DIDANOSINE (DDL) INHIV FROM PATIENTS IN ZDV, DDL AND ALTERNATING ZDV DDL THERAPY/
Authors: NIELSEN C BRUUN L MATHIESEN LR PEDERSEN C GERSTOFT J
Citation: C. Nielsen et al., DEVELOPMENT OF RESISTANCE TO ZIDOVUDINE (ZDV) AND DIDANOSINE (DDL) INHIV FROM PATIENTS IN ZDV, DDL AND ALTERNATING ZDV DDL THERAPY/, AIDS, 10(6), 1996, pp. 625-633
LONGITUDINAL SERUM HIV RNA QUANTIFICATION - CORRELATION TO VIRAL PHENOTYPE AT SEROCONVERSION AND CLINICAL OUTCOME
Authors: KATZENSTEIN TL PEDERSEN C NIELSEN C LUNDGREN JD JAKOBSEN PH GERSTOFT J
Citation: Tl. Katzenstein et al., LONGITUDINAL SERUM HIV RNA QUANTIFICATION - CORRELATION TO VIRAL PHENOTYPE AT SEROCONVERSION AND CLINICAL OUTCOME, AIDS, 10(2), 1996, pp. 167-173
EPIDEMIOLOGY OF CRYPTOSPORIDIOSIS AMONG EUROPEAN AIDS PATIENTS
Authors: PEDERSEN C DANNER S LAZZARIN A GLAUSER MP WEBER R KATLAMA C BARTON SE LUNDGREN JD CLUMECK N DEWIT S SOMMEREIJNS B NIELSEN JO NIELSEN T JENSEN G SKINHOJ P BENTSEN K GERSTOFT J MELBYE M RANKI A VALLE SL BERLUREAU P DIETRICH M SCHWANDER S GOEBEL FD KOSMIDIS J STERGIOU G GOUZIA T PAPADOPOULOS A BANHEGYI D MULCAHY F YUST I BENISHAI Z BENTWICH Z SACKS T MAAYAN S VELLA S CHIESI A ANCARANI F SCALISE G BERTAGGIA A FRANCAVILLA E CALONGHI G EMILIA R CARGNEL A ARLOTTI M CIAMMARUGHI R RIMINI I COLOMBA A DELALLA F FASSIO P FERLINI A FIACCADORI F PASETTI G GIANNELLI F GRILLONE W MONFORTE AD MIGNANI E ANDREA S NUNNARI A ORTONA L PANICHI G PAULUZZI S PIERSANTELLI N RANIERI S RICCIARDIELLO P ROSCIOLI B SORANZO M HEMMER R REISS P ANTUNES F GONZALEZLAHOZ J POLO R CLOTET B GATELL J BUIRA E MIRO J PEHRSON P LUTHY R LEDERGERBER B OLSSON C GLAUSER M HIRSCHEL B JOHNSON A HAWKES S PHILLIPS A BARTON S MORCINEK J PINCHING A COLEMAN D GJORUP I NIEPORT C TEGLBJAERG L THORNVAL A
Citation: C. Pedersen et al., EPIDEMIOLOGY OF CRYPTOSPORIDIOSIS AMONG EUROPEAN AIDS PATIENTS, Genitourinary medicine, 72(2), 1996, pp. 128-131
ASSESSMENTS OF PLASMA HIV RNA AND CD4 CELL COUNTS AFTER COMBINED PNEUMOVAX(R) AND TETANUS TOXOID VACCINATION - NO DETECTABLE INCREASE IN HIV REPLICATION 6 WEEKS AFTER IMMUNIZATION
Authors: KATZENSTEIN TL GERSTOFT J NIELSEN H
Citation: Tl. Katzenstein et al., ASSESSMENTS OF PLASMA HIV RNA AND CD4 CELL COUNTS AFTER COMBINED PNEUMOVAX(R) AND TETANUS TOXOID VACCINATION - NO DETECTABLE INCREASE IN HIV REPLICATION 6 WEEKS AFTER IMMUNIZATION, Scandinavian journal of infectious diseases, 28(3), 1996, pp. 239-241
DEVELOPMENT OF RESISTANCE TO AZT AND DIDANOSINE (DDI) IN HIV FROM PATIENTS IN AZT, DDI, AND ALTERNATING AZT-DDI TREATMENT
Authors: NIELSEN C BRUUN L MATHIESEN LR PEDERSEN C GERSTOFT J
Citation: C. Nielsen et al., DEVELOPMENT OF RESISTANCE TO AZT AND DIDANOSINE (DDI) IN HIV FROM PATIENTS IN AZT, DDI, AND ALTERNATING AZT-DDI TREATMENT, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 44-44
Risultati: 1-25 | 26-31